6xs6
From Proteopedia
(Difference between revisions)
m (Protected "6xs6" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
==SARS-CoV-2 Spike D614G variant, minus RBD== | ==SARS-CoV-2 Spike D614G variant, minus RBD== | ||
- | <StructureSection load='6xs6' size='340' side='right'caption='[[6xs6]]' scene=''> | + | <StructureSection load='6xs6' size='340' side='right'caption='[[6xs6]], [[Resolution|resolution]] 3.70Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6XS6 OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6XS6 FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[6xs6]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/2019-ncov 2019-ncov]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6XS6 OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6XS6 FirstGlance]. <br> |
- | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6xs6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6xs6 OCA], [http://pdbe.org/6xs6 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6xs6 RCSB], [http://www.ebi.ac.uk/pdbsum/6xs6 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6xs6 ProSAT]</span></td></tr> | + | </td></tr><tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">S, 2 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=2697049 2019-nCoV])</td></tr> |
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6xs6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6xs6 OCA], [http://pdbe.org/6xs6 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6xs6 RCSB], [http://www.ebi.ac.uk/pdbsum/6xs6 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6xs6 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/SPIKE_SARS2 SPIKE_SARS2]] attaches the virion to the cell membrane by interacting with host receptor, initiating the infection (By similarity). Binding to human ACE2 receptor and internalization of the virus into the endosomes of the host cell induces conformational changes in the Spike glycoprotein (PubMed:32142651, PubMed:32075877, PubMed:32155444). Uses also human TMPRSS2 for priming in human lung cells which is an essential step for viral entry (PubMed:32142651). Proteolysis by cathepsin CTSL may unmask the fusion peptide of S2 and activate membranes fusion within endosomes.[HAMAP-Rule:MF_04099]<ref>PMID:32075877</ref> <ref>PMID:32142651</ref> <ref>PMID:32155444</ref> mediates fusion of the virion and cellular membranes by acting as a class I viral fusion protein. Under the current model, the protein has at least three conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes.[HAMAP-Rule:MF_04099] Acts as a viral fusion peptide which is unmasked following S2 cleavage occurring upon virus endocytosis.[HAMAP-Rule:MF_04099] | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | The SARS-CoV-2 spike (S) protein variant D614G supplanted the ancestral virus worldwide, reaching near fixation in a matter of months. Here we show that D614G was more infectious than the ancestral form on human lung cells, colon cells, and on cells rendered permissive by ectopic expression of human ACE2 or of ACE2 orthologs from various mammals, including Chinese rufous horseshoe bat and Malayan pangolin. D614G did not alter S protein synthesis, processing, or incorporation into SARS-CoV-2 particles, but D614G affinity for ACE2 was reduced due to a faster dissociation rate. Assessment of the S protein trimer by cryo-electron microscopy showed that D614G disrupts an interprotomer contact and that the conformation is shifted toward an ACE2 binding-competent state, which is modeled to be on pathway for virion membrane fusion with target cells. Consistent with this more open conformation, neutralization potency of antibodies targeting the S protein receptor-binding domain was not attenuated. | ||
+ | |||
+ | Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.,Yurkovetskiy L, Wang X, Pascal KE, Tomkins-Tinch C, Nyalile TP, Wang Y, Baum A, Diehl WE, Dauphin A, Carbone C, Veinotte K, Egri SB, Schaffner SF, Lemieux JE, Munro JB, Rafique A, Barve A, Sabeti PC, Kyratsous CA, Dudkina NV, Shen K, Luban J Cell. 2020 Sep 15. pii: S0092-8674(20)31229-0. doi: 10.1016/j.cell.2020.09.032. PMID:32991842<ref>PMID:32991842</ref> | ||
+ | |||
+ | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
+ | </div> | ||
+ | <div class="pdbe-citations 6xs6" style="background-color:#fffaf0;"></div> | ||
+ | == References == | ||
+ | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
+ | [[Category: 2019-ncov]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Dudkina N]] | + | [[Category: Dudkina, N]] |
- | [[Category: Egri | + | [[Category: Egri, S B]] |
- | [[Category: Luban J]] | + | [[Category: Luban, J]] |
- | [[Category: Shen K]] | + | [[Category: Shen, K]] |
- | [[Category: Wang X]] | + | [[Category: Wang, X]] |
+ | [[Category: D614g]] | ||
+ | [[Category: Sars-cov-2]] | ||
+ | [[Category: Spike]] | ||
+ | [[Category: Viral protein]] |
Revision as of 06:17, 14 October 2020
SARS-CoV-2 Spike D614G variant, minus RBD
|
Categories: 2019-ncov | Large Structures | Dudkina, N | Egri, S B | Luban, J | Shen, K | Wang, X | D614g | Sars-cov-2 | Spike | Viral protein